Cargando…
Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity
PF-543, the most potent sphingosine kinase (SK) inhibitor, does not demonstrate effective anticancer activity in some cancer cells, unlike other known SK1 inhibitors. PF-543 has a non-lipid structure with a unique toluene backbone; however, the importance of this structure remains unclear. Therefore...
Autores principales: | Kim, Su Bin, Lee, Taeho, Moon, Hong Seop, Ki, Sung Hwan, Oh, Yoon Sin, Lee, Joo-Youn, Kim, Sang-Bum, Park, Jeong-Eun, Kwon, Yongseok, Kim, Sanghee, Baek, Dong Jae, Park, Eun-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321251/ https://www.ncbi.nlm.nih.gov/pubmed/32471162 http://dx.doi.org/10.3390/molecules25112484 |
Ejemplares similares
-
Synthesis and Biological Evaluation of BODIPY-PF-543
por: Shrestha, Jitendra, et al.
Publicado: (2019) -
Synthesis of PP2A-Activating PF-543 Derivatives and Investigation of Their Inhibitory Effects on Pancreatic Cancer Cells
por: Kim, Su Bin, et al.
Publicado: (2022) -
Novel Dimer Derivatives of PF-543 as Potential Antitumor Agents for the Treatment of Non-Small Cell Lung Cancer
por: Kim, Su Bin, et al.
Publicado: (2022) -
Determining the Anticancer Activity of Sphingosine Kinase Inhibitors Containing Heteroatoms in Their Tail Structure
por: Shrestha, Jitendra, et al.
Publicado: (2022) -
Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells
por: Hamada, Masakazu, et al.
Publicado: (2017)